Cavaliers’ Tristan Thompson faces 25-game suspension over drug policy breach

Center-forward for Cleveland Cavaliers tested positive for ibutamoren and SARM LGD-4033, both of which are prohibited substances according to NBA

The NBA imposed a 25-game suspension on Tristan Thompson, the center-forward for the Cleveland Cavaliers, due to a breach of the league’s drug policy Tuesday.

Thompson was suspended without pay “for violating the terms of the NBA/NBPA Anti-Drug Program by testing positive for ibutamoren and SARM LGD-4033,” the league said in a statement.

Ibutamoren is a growth hormone stimulator, while SARM LGD-4033 is for building muscles. Both substances are banned by the NBA.

The suspension of the Canadian-born US national, 32, was said to begin on Wednesday, making him miss a game against the Milwaukee Bucks.

“The Cleveland Cavaliers fully support the NBA/NBAPA Anti-Drug Program, and we are disappointed in the recent news surrounding Tristan Thompson. His time away from game action will have an impact on our team. We stand behind Tristan and offer our support throughout this suspension period,” the Eastern Conference team said.

Thompson, an NBA player since 2011, helped the Cavaliers win the league title in 2016.

He also played for the Boston Celtics, Sacramento Kings, Indiana Pacers, Chicago Bulls and Los Angeles Lakers before returning to the Cavaliers in 2023.

Source: Anadolu Agency